""This is part of the integration following the close of the Arcellx acquisition. These decisions are never taken lightly, and our focus is on supporting employees through this transition with transparency and respect.""
""With the Arcellx acquisition, our focus turns to executing with speed and discipline as we prepare to bring anito-cel to patients," Cindy Perettie, executive vice president and global head of Kite Pharma, stated."
Gilead Sciences is laying off 108 employees from its Redwood City offices, following a previous layoff of 104 workers. The layoffs will occur between June 30 and April 30, 2027, impacting positions in manufacturing, quality assurance, marketing/sales, and clinical development, including senior directors and vice presidents. Gilead also let go of 84 employees in Rockville, Maryland. The layoffs are part of the integration after acquiring Arcellx for approximately $7.8 billion, with a focus on executing plans for new therapies.
Read at SFGATE
Unable to calculate read time
Collection
[
|
...
]